PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis

Qin, Y; Hu, QS; Xu, J; Ji, SR; Dai, WX; Liu, WS; Xu, WY; Sun, QQ; Zhang, Z; Ni, QX; Zhang, B; Yu, XJ; Xu, XW

Yu, XJ; Xu, XW (reprint author), Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai 200032, Peoples R China.

CELL COMMUNICATION AND SIGNALING, 2019; 17 ():